Prenatal aspects in spinal muscular atrophy: From early detection to early presymptomatic intervention

Area of Science:

• Neurology
• Genetics
• Pediatrics

Background:

• Spinal muscular atrophy (SMA) is a progressive genetic neuromuscular disorder.
• Recent therapeutic advancements are significantly altering the standard of care for SMA.
• Emerging phenotypes and evolving patient expectations necessitate a reevaluation of clinical management.

Purpose of the Study:

• To outline the changing landscape of standard care and follow-up for spinal muscular atrophy.
• To emphasize the critical role of early intervention in optimizing treatment response and prognosis.
• To highlight the importance of understanding prenatal and pre-symptomatic stages for timely diagnosis and therapeutic decisions.

Main Methods:

• Review of current evidence on spinal muscular atrophy therapies.
• Analysis of emerging clinical phenotypes and patient-reported outcomes.
• Synthesis of knowledge regarding prenatal and pre-symptomatic disease stages.

Main Results:

• Therapeutic advances are creating new possibilities for SMA management.
• Early intervention is consistently linked to better treatment efficacy and prognosis.
• Understanding disease progression from prenatal stages is key for early intervention.

Conclusions:

• The standard of care for SMA is rapidly evolving due to new therapies.
• Timely diagnosis and intervention, informed by prenatal and pre-symptomatic knowledge, are essential for optimal SMA patient outcomes.